Search clinical trials for: non responder

Total 53477 results

Hoffmann-La Roche

Terminated

A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Hepatitis C, Chronic

Belgium
Samsung Medical Center
Seok Jin Kim

Terminated

Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma (ZOLINZA)

Mantle Cell Lymphoma

Korea, Republic of
Prof. Abid Z. Farooqi
Aga Khan University; Fatima Memorial Hospital; Fauji Foundation Hospital, Rawalpindi

Completed

Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS) (PARIS)

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.

Hepatitis C, Chronic

France
Debiopharm International SA

Completed

A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Chronic Hepatitis C

United States
Asociación Andaluza de Hematología y Hemoterapia

Completed

Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia (ABRAZA)

Myelodysplastic Syndrome (MDS)

Spain
Samsung Medical Center

Unknown

Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype

Depression

Korea, Republic of
University Hospitals, Leicester

Completed

A Study of Triple-site Ventricular Pacing in Patients Who Have Not Responded to Conventional Dual Ventricular Site Cardiac Resynchronization Therapy (TRIVENT)

Heart Failure

United Kingdom
University of Calgary
Heart and Stroke Foundation of Canada

Unknown

Torsion Optimization to Reduce Symptoms and Improve Outcomes in Non-responders (TORSION)

Heart Failure, Congestive

Canada
Sang Hyun Ihm, MD PhD
Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM (EARTH)

Hypertension

Korea, Republic of
Beijing 302 Hospital

Unknown

Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection

Human Immunodeficiency Virus

China
University Hospital, Geneva

Completed

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

Chronic Hepatitis C

Switzerland
Catharina Ziekenhuis Eindhoven

Withdrawn

Endocardial Pacing in On-table Non-responders in Cardiac Resynchronization Therapy

Heart Failure

Netherlands
AbbVie (prior sponsor, Abbott)

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Hepatitis C | Hepatitis C Virus | Chronic Hepatitis C Infection

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients

Chronic Hepatitis C

Japan
National Institute of Diabetes and Digestive and...

Completed

High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1

Chronic Hepatitis C

United States
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC; Rennes University Hospital

Completed

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

Hepatitis C, Chronic | Liver Fibrosis

France, Belgium
Boehringer Ingelheim

Completed

Filtered Trial for Amlodipine Non-responder

Hypertension

Japan
Boehringer Ingelheim

Completed

Telmisartan 80mg Non-responder Trial

Hypertension

Japan
University Hospital, Bonn

Terminated

Cardiac MR (CMR) in Cardiac Resynchronization Therapy Non-responders

Heart Failure

Germany
Boehringer Ingelheim

Completed

Filtered Trial for Telmisartan 40mg Non-responder

Hypertension

Japan
University of Colorado, Denver
American Cancer Society, Inc.; Eisai Inc.

Completed

A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression

Thyroid Cancer

United States
GlaxoSmithKline

Completed

Clinical Trial for Non-responders Who Previously Participated in Eltrombopag Studies TPL 103922 or TPL 108390 (ENABLE-ALL)

Hepatitis C

United States, Australia, Germany, France, Canada, Spain, Greece, Pakistan, Italy
LI Taisheng

Completed

Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses

HIV

China
S.F.L. van Lelyveld
Pfizer; Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van... and other collaborators

Completed

Maraviroc Immune Recovery Study (MIRS)

HIV Infections

Netherlands
Cytheris SA

Terminated

Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders (Inspire 3)

HIV

Switzerland, Italy, South Africa
National Institute of Diabetes and Digestive and...

Completed

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Chronic Hepatitis C

United States
Amgen

Completed

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

Rheumatoid Arthritis
ASST Fatebenefratelli Sacco

Completed

Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects

HIV Infections

Italy
National Center for Tumor Diseases, Heidelberg

Terminated

Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG) (HICON)

Adenocarcinomas of the Esophagogastric Junction

Germany
Centocor, Inc.

Completed

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Crohn's Disease

United States, France, United Kingdom, Germany, Spain, Belgium, Israel, Australia, Canada, Netherlands, New Zealand, Austria
ANRS, Emerging Infectious Diseases
Roche Pharma AG

Completed

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV (ETOC)

Hepatitis

France
LI Taisheng

Unknown

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders (CACTrip12)

HIV

China
Wyeth is now a wholly owned subsidiary of Pfizer
ViroPharma

Completed

A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects

Hepatitis C

United States, Puerto Rico
Hospital Universitario Ramon y Cajal

Terminated

Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis (RIBACIR)

Chronic Hepatitis C

Spain
Rambam Health Care Campus
Medispec

Completed

The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders (LI-ESWT)

Erectile Dysfunction
Chong Kun Dang Pharmaceutical

Completed

CKD-828 S-Amlodipine Non-Responder Trial

Hypertension

Korea, Republic of
Hamad Medical Corporation

Unknown

Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient

RHEUMATOID ARTHRITIS

Qatar
University of Aarhus
Aarhus University Hospital; Monash Medical Centre

Unknown

Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders

Hepatitis B

Denmark
Kadmon Corporation, LLC

Terminated

Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin (ENHANCE)

Hepatitis C

United States
Chong Kun Dang Pharmaceutical

Completed

CKD-828 Telmisartan Non-Responder Trial

Hypertension

Korea, Republic of
Bausch Health Americas, Inc.

Completed

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Chronic Hepatitis C
Novartis Pharmaceuticals

Terminated

A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients

Hepatitis C

New Zealand
Jiangsu Province Centers for Disease Control and...
Shenzhen Kangtai Biological Products Co., LTD

Completed

The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines

Hepatitis b
Nematollah Jonaidi Jafari

Unknown

Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine

Hepatitis B | Vaccination Failure

Iran, Islamic Republic of
Brooke Army Medical Center

Completed

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Hepatitis c

United States
Inspira Medical AB
NasVax Ltd

Unknown

Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects

Chronic Hepatitis C

Austria, Poland
AstraZeneca

Completed

Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

Non-Small Cell Lung Cancer

Netherlands
AstraZeneca

Completed

A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders (RESPOND)

Stable Coronary Artery Disease

United States, Canada, Denmark, United Kingdom
Rambam Health Care Campus
Medispec

Completed

The Effect of Low Intensity Shockwave Therapy for ED in Post Radical Prostatectomy Patients Who Didn't Respond to PDE5i (LI-ESWT)

Erectile Dysfunction

Israel

3

Subscribe